Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of MDCX will decline by -37.58% over the next 2 Weeks and hit $0.11 by Friday, October 2, 2026. In that time frame, MDCX's share price is expected to range between $0.07 and $0.14.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Oct 2, 2026 | 0.09 | 0.12 | 0.15 |
| Oct 1, 2026 | 0.11 | 0.14 | 0.17 |
| Sep 30, 2026 | 0.11 | 0.15 | 0.18 |
| Sep 29, 2026 | 0.11 | 0.15 | 0.18 |
| Sep 28, 2026 | 0.12 | 0.15 | 0.18 |
| Sep 25, 2026 | 0.11 | 0.14 | 0.18 |
| Sep 24, 2026 | 0.13 | 0.17 | 0.20 |
| Sep 23, 2026 | 0.14 | 0.17 | 0.21 |
| Sep 22, 2026 | 0.14 | 0.17 | 0.21 |
| Sep 21, 2026 | 0.14 | 0.18 | 0.21 |
MDCX shares fell -0.18% in Friday, September 18, 2026's trading session, dropping from a previous close of $0.17 to move at $0.17. The stock demonstrated notable intraday movement (see MDCX's key stats for a full breakdown), fluctuating between $0.17 and $0.18, a +4.53% trading range. While recent weeks have seen some volatility, MDCX has managed to secure a -0.99% drop over the past 2 weeks. The downward price movement was accompanied by decreased trading volume, with approximately 2.97M shares changing hands, 16.37M fewer than the previous session. This amounted to $506.22K in total market activity.
Will MDCX Continue Its Downward Trend?
According to analyst ratings and projections for MDCX, Medicus Pharma Ltd. Common Stock shares are anticipated to decrease by -12.31%, potentially reaching $0.15 per share by October 2, 2026. Short-term technical indicators for MDCX currently suggest a bearish sentiment. Despite this, the stock appears to be in a state of indecision, having seen 15 positive and 15 negative trading days over the last 30 sessions. Based on the MDCX stock forecast, now is not the best time to buy MDCX stock because its current trading price is +46.05% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on MDCX covering social and institutional perspectives.
MDCX Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into MDCX's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 33.17% to 35.17%) suggest the stock is in a weak bearish momentum phase. The 50-day RSI, at 39.95%, hints at potential weakness developing in the medium term. Additionally, the 100-day RSI, at 43.11%, maintains a neutral outlook for the long term. Insights into MDCX's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Medicus Pharma Common Stock Short-Term Forecasts
MDCX Forecast For Next 5 Days
Our algorithm anticipates Medicus Pharma Common Stock (MDCX) stock could hit $0.14 by Sep 25, 2026. This represents a -16.56% fall from today's price, following a -6.16% change over the past five days.
MDCX Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Medicus Pharma Ltd. Common Stock (MDCX) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $0.12, which would mean a -29.54% decrease from the current price of $0.17. Projections for this period range from a high of $0.20 to a low of $0.05.
MDCX Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Medicus Pharma Common Stock's price over the next three months point to a rise. MDCX stock is expected to peak at $1.17 on Nov 17, 2026 after potentially dipping to $0.40 on Sep 29, 2026. On average, MDCX is likely to trade around $0.81 in the coming 90 days.
Medicus Pharma Common Stock Stock Forecast 2025
Based on our predictive models, Medicus Pharma Common Stock (MDCX) is expected to trade between $0.40 and $1.17 throughout 2026. This would result in an average price of $0.81, potentially offering investors a +375.63% return from current levels.
Medicus Pharma Ltd. Common Stock Monthly Forecast 2026–2027
September 2026
According to our latest forecast models, Medicus Pharma Ltd. Common Stock (MDCX) is positioned to show a strong performance in September 2026. The price is predicted to move between $0.40 and $0.62, settling at an average of $0.51. This could translate to a +199.47% gain.
October 2026
Based on current market signals, Medicus Pharma Ltd. Common Stock is projected to trend october 2026. We forecast a trading range from $0.40 to $0.91, with a likely average price of $0.67. Investors could expect a potential return of +293.42%.
November 2026
Our predictive algorithms indicate Medicus Pharma Ltd. Common Stock stock may see a shift in November 2026. The expected range spans $0.80–$1.17, with an average target of $1.01. This represents a positive outlook and a possible gain of +493.07%.
December 2026
Analyzing established trends, Medicus Pharma Ltd. Common Stock looks set to move in December 2026. Projections place the stock between $0.54 and $1.03, averaging around $0.87. This suggests a +410.86% gain from current levels.
January 2027
Market indicators suggest Medicus Pharma Ltd. Common Stock could experience notable changes during January 2027. Prices could fluctuate within $0.29 to $0.82, with a midpoint forecast of $0.59. The stock might deliver a +246.45% gain.
February 2027
Forecasting for February 2027, models estimate that Medicus Pharma Ltd. Common Stock may undergo key fluctuations. If trends hold, the stock might trade between $0.17 and $0.58, averaging $0.43. This signals a positive trajectory with potential returns around +152.50%.
March 2027
According to our latest forecast models, Medicus Pharma Ltd. Common Stock (MDCX) is positioned to show a strong performance in March 2027. The price is predicted to move between $0.00 and $0.36, settling at an average of $0.14. This could translate to a -17.79% loss.
April 2027
Based on current market signals, Medicus Pharma Ltd. Common Stock is projected to trend april 2027. We forecast a trading range from $0.00 to $0.27, with a likely average price of $0.19. Investors could expect a potential return of +11.57%.
May 2027
Our predictive algorithms indicate Medicus Pharma Ltd. Common Stock stock may see a shift in May 2027. The expected range spans $0.00–$0.14, with an average target of $0.18. This represents a positive outlook and a possible gain of +5.70%.
June 2027
Analyzing established trends, Medicus Pharma Ltd. Common Stock looks set to move in June 2027. Projections place the stock between $0.00 and $0.09, averaging around $0.09. This suggests a -47.15% loss from current levels.
July 2027
Market indicators suggest Medicus Pharma Ltd. Common Stock could experience notable changes during July 2027. Prices could fluctuate within $0.00 to $0.00, with a midpoint forecast of $0.11. The stock might deliver a -35.41% loss.
August 2027
Forecasting for August 2027, models estimate that Medicus Pharma Ltd. Common Stock may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.09, averaging $0.03. This signals a cautious trajectory with potential returns around -82.38%.
September 2027
According to our latest forecast models, Medicus Pharma Ltd. Common Stock (MDCX) is positioned to show a strong performance in September 2027. The price is predicted to move between $0.00 and $0.00, settling at an average of $0.12. This could translate to a -29.54% loss.
MDCX's history of dividends and stock splits also plays a role in long-term investor confidence.